Does Arterial Spin-labeling MR Imaging–measured Tumor Perfusion Correlate with Renal Cell Cancer Response to Antiangiogenic Therapy in a Mouse Model?-Reference-Cited by-同舟云学术

Does Arterial Spin-labeling MR Imaging–measured Tumor Perfusion Correlate with Renal Cell Cancer Response to Antiangiogenic Therapy in a Mouse Model?

Published:2009-06 Issue:3 Volume:251 Page:731-742
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Schor-Bardach Rachel,Alsop David C.,Pedrosa Ivan,Solazzo Stephanie A.,Wang Xiaoen,Marquis Robert P.,Atkins Michael B.,Regan Meredith,Signoretti Sabina,Lenkinski Robert E.,Goldberg S. Nahum

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2521081059

Reference54 articles.

1. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

2. Sorafenib for the Treatment of Advanced Renal Cell Carcinoma

3. Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review

4. Recent Progress in the Management of Advanced Renal Cell Carcinoma

5. Treatment options in renal cell carcinoma: past, present and future

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioprinted research models of urological malignancy;Exploration;2024-02-20

2. Imaging Techniques and Clinical Application of the Marrow–Blood Barrier in Hematological Malignancies;Diagnostics;2023-12-21

3. MR Virtual Biopsy of Solid Renal Masses: An Algorithmic Approach;Cancers;2023-05-17

4. Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysis;Urologic Oncology: Seminars and Original Investigations;2021-11

5. New frontiers against sorafenib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers;Pharmacological Research;2021-08